| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |